People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Freenome Holdings, Inc. | — | Other | Series D+ | $750.6M | $3.4B | 2017 |
| Oncolinx Pharmaceuticals, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $16.6M | 2014 |
Riley Ennis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Riley Ennis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amir Nashat | 1 | 14 |
| Vijay Pande | 1 | 9 |
| Peter Kolchinsky | 1 | 8 |
| Randal Scott | 1 | 4 |
| Charles Roberts | 1 | 4 |
| Gabriel Otte | 1 | 3 |
| Ellen Hukkelhoven | 1 | 2 |
| Michael Nolan | 1 | 1 |
| Sourav Sinha | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.